Streetbeat News

Stock Prices

GNLX

Genelux Corporation's stock is trading higher following the announcement that the FDA has granted Fast Track designation to its development program for Olvi-Vec, aimed at treating patients with platinum-resistant/refractory ovarian cancer.

Portfolio Pulse from Benzinga Newsdesk

December 01, 2023 | 6:13 pm

RIVN

TSLA

Tesla Inc (NASDAQ:TSLA) showcased the first deliveries of its Cybertruck, with analysts providing mixed reactions. Goldman Sachs maintains a Neutral rating with a $235 price target, Morgan Stanley an Overweight rating with a $380 target, and RBC Capital Markets an Outperform rating with a $301 target. Analysts predict Cybertruck will represent 5% of Tesla's revenue and negligible profit by 2025. Comparisons were made to Ford Motor Co (NYSE:F) and Rivian Automotive (NASDAQ:RIVN), with concerns about the Cybertruck's high price point and its impact on reservation conversion rates.

Portfolio Pulse from Chris Katje

December 01, 2023 | 6:11 pm

ULTA

Piper Sandler analyst Korinne Wolfmeyer has maintained an Overweight rating on Ulta Beauty (NASDAQ: ULTA) and increased the price target from $540 to $572.

Portfolio Pulse from Benzinga Newsdesk

December 01, 2023 | 6:10 pm

BKKT

CLSK

COIN

HIVE

MARA

RIOT

Bitcoin (BTC/USD) reached approximately $39K, the highest level since May 2022, despite regulatory pressures. The cryptocurrency market's total capitalization surpassed $1.5 trillion. Crypto-related stocks like Coinbase (COIN), Marathon Digital (MARA), Riot Platforms (RIOT), Bakkt Holdings (BKKT), and HIVE Digital Technologies (HIVE) are rising in response. MicroStrategy continues to purchase Bitcoin, and CleanSpark (CLSK) reported mining 666 bitcoins in November, holding 2.575 bitcoins as of November 30.

Portfolio Pulse from Lekha Gupta

December 01, 2023 | 6:09 pm

FSR

Fisker Inc. reported that as of November 30, it had 123 vehicles delivered or in transit to customers, which has led to an increase in its stock price.

Portfolio Pulse from Benzinga Newsdesk

December 01, 2023 | 6:09 pm

JNJ

KVUE

UBS has upgraded Johnson & Johnson (NYSE:JNJ) from Neutral to Buy with a new price target of $180, citing a bullish outlook on its pharmaceutical business and MedTech growth. JNJ's recent spinoff of its consumer health company Kenvue Inc (NYSE:KVUE) allows it to focus on healthcare and MedTech. Despite concerns over talc litigation impacting JNJ's stock, UBS is confident in JNJ's ability to outperform consensus expectations in Pharma sales and achieve MedTech growth.

Portfolio Pulse from Vandana Singh

December 01, 2023 | 6:05 pm

CLF

CMA

HUM

On CNBC's Halftime Report, experts shared their final trades, which included Comerica, Humana, and Cleveland-Cliffs. These stock picks are highlighted as potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

December 01, 2023 | 6:01 pm

CVNA

Carvana (NYSE:CVNA) has received 7 analyst ratings in the last quarter, with 5 being indifferent and 2 somewhat bearish. No bullish ratings were given. The average 12-month price target for Carvana is now $37.71, down from the previous $42.60, marking an 11.48% decrease. The high target is $48.00 and the low is $24.00. Analysts' ratings are based on financial predictions and company performance metrics.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 6:00 pm

STZ

Constellation Brands (NYSE:STZ) has seen a 13.43% increase in short interest since its last report, with 1.35 million shares sold short, representing 0.76% of available shares. It would take about 1.15 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, STZ has less short interest compared to its peers' average of 4.21%. The rise in short interest doesn't necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 6:00 pm

WELL

Over the past 15 years, Welltower (NYSE:WELL) has produced an average annual return of 15.86%, outperforming the market by 4.47% on an annualized basis. A $100 investment in WELL 15 years ago would be worth $905.62 today. Welltower's market capitalization currently stands at $48.41 billion.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 6:00 pm